U.S. COMPANY FILING
REGENERON PHARMACEUTICALS, INC. — Form 8-K filed 2026-04-29
Filing text preview
Regeneron Pharmaceuticals reported its first quarter 2026 financial and operating results on April 29, 2026, via a press release furnished as an exhibit to the 8-K. The filing does not include specific financial figures.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record